ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

4-Methylmorpholine → 2-[[3-[[[2-[(4-Cyclohexylbutyl)-amino]-1-(hydroxymethyl)-2-oxoethyl]amino]carbonyl]-7-oxabicyclo[2.2.1]hept-2-yl]methyl]-4-fluoro-1-phenylmethoxy-benzene

HRID 252233
印刷

反応式

HRID 252233 の反応式
[C:1]([CH:4]1[CH:9]2[O:10][CH:6]([CH2:7][CH2:8]2)[CH:5]1[CH2:11][C:12]1[CH:17]=[C:16]([F:18])[CH:15]=[CH:14][C:13]=1[O:19][CH2:20][C:21]1[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=1)(O)=[O:2].[NH2:27][C@H:28]([C:31]([NH2:33])=[O:32])[CH2:29][OH:30].CN1[CH2:40][CH2:39]OCC1.CCN=C=N[CH2:46][CH2:47][CH2:48]N(C)C>CN(C)C=O>[CH:48]1([CH2:47][CH2:46][CH2:39][CH2:40][NH:33][C:31](=[O:32])[CH:28]([NH:27][C:1]([CH:4]2[CH:9]3[O:10][CH:6]([CH2:7][CH2:8]3)[CH:5]2[CH2:11][C:12]2[CH:17]=[C:16]([F:18])[CH:15]=[CH:14][C:13]=2[O:19][CH2:20][C:21]2[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=2)=[O:2])[CH2:29][OH:30])[CH2:8][CH2:9][CH2:4][CH2:5][CH2:6]1
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 4

HCID 79724-MethylmorpholineHCID 159081-Ethyl-3-(3'-dimethylaminopropyl)carbodiimideHCID 101138L-SerinamideHCID 597080212-[[3-Carboxy-7-oxabicyclo[2.2.1]hept-2-yl]methyl]-4-fluoro-1-phenylmethoxybenzene

生成物 1

HCID 597080272-[[3-[[[2-[(4-Cyclohexylbutyl)-amino]-1-(hydroxymethyl)-2-oxoethyl]amino]carbonyl]-7-oxabicyclo[2.2.1]hept-2-yl]methyl]-4-fluoro-1-phenylmethoxy-benzene

試薬・触媒・溶媒 1

HCID 6228Dimethylformamide溶媒

実験手順

To a solution of [1S-(1α, 2α, 3α, 4α)]-2-[[3-Carboxy-7-oxabicyclo[2.2.1]hept-2-yl]methyl]-4-fluoro-1-phenylmethoxybenzene (0.3 g, 0.825 mmol), N-(4-cyclohexyl)butyl)-L-serinamide (0.2 g, 0.825 mmol), HBOt (0.122 g, 0.91 mmol), 4-methylmorpholine (0.1 mL, 0.91 mmol) in dimethylformamide (5 mL), at 0° C. and under nitrogen atmosphere, was added portion-wise EDAC (0.174 g, 0.91 mmol). The resulting mixture was stirred for 10 minutes then it was allowed to warm slowly to room temperature and stirred for 16 h. After this time, the reaction was stopped and the solvent was evaporated under vacuum. The crude material was partitioned between ethyl acetate (15 mL) and 2M HCl (10 mL). The organic phase was separated; it was washed with a sat. solution of sodium bicarbonate (10 mL), Brine (10 mL), dried (MgSO4), filtered and the solvent evaporated “under vacuum” to give the titled product as an oil which was used in the next step without any additional purification. 1H-NMR (CDCl3, 300 MHz) δ 7.30 (m, 5H, ArH), 7.03 (t, 1H, J=5.8 Hz, CONH), 6.80 (m, 4H, ArH+NH), 5.03 (s, 2H, —OCH2Ph), 4.69 (d, 1H, J=5.1 Hz, —CH—O—), 4.42 (m, 1H, —CONHCHCO—), 4.33 (d, 1H, J=5.1 Hz, —CH—O—), 3.97 (dd, 1H, J=3.8, 11.3 Hz, —CH2OH), 3.56 (dd, 1H, J=5.5, 11.3 Hz, —CH2OH), 3.12 (m, 2H, —NCH2—), 2.73-2.40 (m, 4H, —CH—+—CH2—), 1.63-0.70 (m, 21H, —CH2—CH2—)

後処理

  1. stirringstirred for 16 h
  2. customthe solvent was evaporated under vacuum
  3. customThe crude material was partitioned between ethyl acetate (15 mL) and 2M HCl (10 mL)
  4. customThe organic phase was separated
  5. washit was washed with a sat. solution of sodium bicarbonate (10 mL), Brine (10 mL)
  6. dry with materialdried (MgSO4)
  7. filtrationfiltered
  8. customthe solvent evaporated “under vacuum”

出典と根拠

ORDレコード
ord-b11905747baf4dc9834cb30ff6da31cd
出典データセット
uspto-grants-2011_01
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07868032B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート